Showing results (71-80 of 254) with videos related to
Sort By:
Pageof 26
FEBS Letters|January 26, 2025
Endothelial lipase-binding peptides similar to netrin-1 inhibit hepatitis B virus infectionMayuko Ide, Noriko Tabata, Kazuhisa Murai, et al.Liver Cancer|April 26, 2019
Surrogacy of Time to Progression for Overall Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsTakeshi Terashima, Tatsuya Yamashita, Tadashi Toyama, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 31, 2018
Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapyTakeshi Terashima, Tatsuya Yamashita, Hajime Sunagozaka, et al.Biochemical and Biophysical Research Communications|October 13, 2012
Association of changes in the gene expression profile of blood cells with the local tumor inflammatory response in a murine tumor modelYoshio Sakai, Isamu Tatsumi, Mami Higashimoto, et al.Biochemical and Biophysical Research Communications|August 5, 2010
Differential gene expression profiling in blood from patients with digestive system cancersMasao Honda, Yoshio Sakai, Taro Yamashita, et al.International Journal of Molecular Sciences|January 24, 2018
Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In VitroKazuhisa Murai, Takayoshi Shirasaki, Masao Honda, et al.Cancer Science|April 2, 2015
Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impactTakuya Komura, Yoshio Sakai, Kenichi Harada, et al.Oncology|December 3, 2011
Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinomaTatsuya Yamashita, Kuniaki Arai, Hajime Sunagozaka, et al.BMC Cancer|June 2, 2016
Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinomaTakeshi Terashima, Tatsuya Yamashita, Rika Horii, et al.Journal of Hepatology|August 27, 2010
Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis CMasao Honda, Mikiko Nakamura, Makoto Tateno, et al.Pageof 26